» Articles » PMID: 23317767

Underdiagnosis of Chronic Obstructive Pulmonary Disease in Women: Quantification of the Problem, Determinants and Proposed Actions

Overview
Specialty Pulmonary Medicine
Date 2013 Jan 16
PMID 23317767
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The distribution of chronic obstructive pulmonary disease (COPD) in women, and its underdiagnosis and determinants in the general population, have not been well described. The EPI-SCAN study is an epidemiologic, observational study conducted at 11 Spanish centers on the general population aged 40 to 80.

Patients And Method: This paper describes the rates and extrapolates the population burden from the 3,802 participants of the EPI-SCAN study.

Results: With 2,005 female and 1,797 male participants, there was a lower prevalence of COPD in women (5.7%; 95%CI, 4.7-6.7) than in men (15.1%; 95%CI, 13.5-16.8; P<.05). Among the 386 participants with COPD, 114 (29.5%) were women, who were younger, currently smoked less and had lower tobacco smoke exposure, while reporting a lower level of education (P<.05). As for the respiratory symptoms, there were no differences between sexes for cough, dyspnea or wheezing, but the women with COPD reported sputum less frequently (P<.05). There were no differences in the spirometric severity of COPD between women and men. Overall, 73% of the patients with a spirometric COPD criteria were underdiagnosed, and this percentage is unevenly distributed by sex, being 1.27 times more frequent in women (86.0%) than in men (67.6%) (P<.05). By extrapolating the rates of prevalence and underdiagnosis of COPD to the general population, we estimate that there are 628,102 Spanish women between the ages of 40 and 80 with COPD, 540,168 of whom still have not been diagnosed.

Conclusions: There is a greater underdiagnosis of COPD in women than in men in Spain.

Citing Articles

Temporal trends, gender, and ethnoracial disparities in mortality from pulmonary emphysema: A retrospective nationwide analysis.

Saeed H, Arshad M, Shahnoor S, Abdullah , Wasay A, Mahmood H Medicine (Baltimore). 2025; 103(52):e41032.

PMID: 39969366 PMC: 11688024. DOI: 10.1097/MD.0000000000041032.


Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients.

Fekete M, Horvath A, Santa B, Abonyi-Toth Z, Tomisa G, Szollosi G Int J Chron Obstruct Pulmon Dis. 2024; 19:2671-2688.

PMID: 39677832 PMC: 11639957. DOI: 10.2147/COPD.S484664.


Artificial Intelligence Applied to Forced Spirometry in Primary Care.

Moreno Mendez R, Marin A, Ferrando J, Rissi Castro G, Cepeda Madrigal S, Agostini G Open Respir Arch. 2024; 6(Suppl 2):100313.

PMID: 38828405 PMC: 11137334. DOI: 10.1016/j.opresp.2024.100313.


Proteomic Blood Profiles Obtained by Totally Blind Biological Clustering in Stable and Exacerbated COPD Patients.

Enriquez-Rodriguez C, Pascual-Guardia S, Casadevall C, Caguana-Velez O, Rodriguez-Chiaradia D, Barreiro E Cells. 2024; 13(10.

PMID: 38786086 PMC: 11119172. DOI: 10.3390/cells13100866.


Addressing the ethical problem of underdiagnosis in the post-pandemic Canadian healthcare system.

Camillo C Healthc Manage Forum. 2023; 36(6):420-423.

PMID: 37711025 PMC: 10604383. DOI: 10.1177/08404704231200113.